List of works - Zvavahera M Chirenje

Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study

scientific article

Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial

scientific article

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women

scientific article published on 25 February 2016

Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe

article

Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial

scientific article published on 17 February 2017

Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [contraception 2016; 93 (1): 25-31].

scientific article published on 14 April 2016

Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe

scientific article published on 8 April 2017

Impact of contraceptive initiation on vaginal microbiota.

scientific article

Misreporting of contraceptive hormone use in clinical research participants.

scientific article published on 28 September 2017

Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial

scientific article

Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial

scientific article

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

scientific article

The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe

article

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

scientific article published on 22 February 2016

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

article

Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel ⬇️

scientific article published on August 27, 2012

List of works by Zvavahera M Chirenje

Acceptability of heat treating breast milk to prevent mother-to-child transmission of human immunodeficiency virus in Zimbabwe: a qualitative study

Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial

An Empiric HIV Risk Scoring Tool to Predict HIV-1 Acquisition in African Women

Anal human papillomavirus infection in HIV-positive men and women at two opportunistic infections clinics in Harare, Zimbabwe

Contraceptive Use and Pregnancy Incidence Among Women Participating in an HIV Prevention Trial

Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [contraception 2016; 93 (1): 25-31].

Genotypic diversity of anogenital human papillomavirus in women attending cervical cancer screening in Harare, Zimbabwe

Impact of contraceptive initiation on vaginal microbiota.

Misreporting of contraceptive hormone use in clinical research participants.

Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial

Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial

Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women

The association of puerperal sepsis with HIV infection at two tertiary hospitals in Zimbabwe

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel ⬇️